IntegraGen is a genomics company based in France that provides DNA sequencing and genotyping services. It serves research institutions, hospitals and biotechnology companies, offering high-throughput sequencing and genetic analysis for studies of disease, including work in autism and cancer genomics. The company also develops molecular diagnostic tests and provides genomic testing services to clinical and academic customers, combining laboratory analysis with bioinformatics support for interpreting genetic data.
Integragen trades under the code ALINT on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #609 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendWeak
8/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-35.9%
From 52-week high-71.2%
MomentumWeak
14/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-23.2%
6-month return-38.1%
12-month, skipping last month-51.7%
Stability (higher is calmer)Weak
1/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)233.5%
Worst drawdown, 1 year (smaller is calmer)-96.2%
LiquidityWeak
31/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 0.013 – 0.361Daily closes, split-adjusted
Signals
50-day average0.114
200-day average0.162
Golden/death cross (60d)Death, 41 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.020
Technical summary
Daily
Bearish
6 bullish · 1 neutral · 9 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
0.05
Bullish
EMA 10
0.06
Bullish
SMA 20
0.06
Bullish
EMA 20
0.07
Bullish
SMA 50
0.11
Bearish
EMA 50
0.10
Bullish
SMA 100
0.14
Bearish
EMA 100
0.13
Bearish
SMA 200
0.16
Bearish
EMA 200
0.16
Bearish
Oscillators (daily)
RSI (14)
58.49
Neutral
MACD (12, 26)
-0.01
Bearish
Momentum (12)
151.2
Bullish
Stochastic %K (14)
88.35
Bearish
Williams %R (14)
-11.65
Bearish
CCI (20)
169.2
Bearish
Pivot points (classic, last session)
S3
0.05
S2
0.06
S1
0.08
Pivot
0.10
R1
0.12
R2
0.14
R3
0.16
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
